The shingles vaccine can make your arm sore and give you muscle aches or fatigue for a day or two, and lots of people feel this — but it’s not serious and almost no one quits the study because of it.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim reports specific percentages from clinical trial data, which are derived from controlled studies. The use of 'causes' is acceptable in this context because the trial design (randomized, placebo-controlled) supports causal inference for adverse events. However, 'causes' implies direct causation, which is better expressed probabilistically given that not every recipient experiences reactions. The claim correctly qualifies the reactions as transient and rarely leading to discontinuation, which aligns with safety reporting standards. The verb 'causes' could be softened to 'is associated with' for maximum precision, but in vaccine safety literature, 'causes' is commonly and acceptably used when supported by RCT data.
More Accurate Statement
“The adjuvanted herpes zoster subunit vaccine (HZ/su) is associated with a higher frequency and severity of local (e.g., injection-site pain) and systemic (e.g., myalgia) reactions compared to placebo, with 81.5% of recipients reporting injection-site pain and 66.1% reporting systemic reactions; however, these reactions are transient and rarely lead to study discontinuation.”
Context Details
Domain
medicine
Population
human
Subject
The adjuvanted herpes zoster subunit vaccine (HZ/su)
Action
causes
Target
more frequent and severe local and systemic reactions than placebo, with specific rates of injection-site pain (81.5%) and systemic reactions (66.1%), which are transient and rarely lead to study discontinuation
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
This study gave the shingles vaccine to older adults and found that most got a sore arm or felt achy, but it didn’t last long and almost no one quit the study because of it — just like the claim says.